Form 4: Itron CEO Thomas Deitrich Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Itron's President and CEO, Thomas Deitrich, exercised stock options and sold shares of common stock on October 1, 2024, according to a Form 4 filing with the SEC.
Summary
- On October 1, 2024, Thomas Deitrich, President & CEO of Itron, Inc. exercised stock options to acquire 37,500 shares of Itron common stock at a price of $35.13 per share.
- Concurrently, Deitrich sold a total of 37,500 shares of Itron common stock on the same day.
- The sales were executed in multiple transactions at weighted average prices of $103.983 for 400 shares, $104.622 for 25,013 shares, and $105.278 for 12,087 shares.
- These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 6, 2025.
- Following these transactions, Deitrich directly owns 205,276 shares and indirectly owns 25,000 shares through a trust.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading strategy, and there's no indication of unusual activity or concern.
Future Outlook
The filing does not contain any specific forward-looking statements, but the Rule 10b5-1 trading plan suggests a pre-determined strategy for future transactions.
Industry Context
Executive stock transactions are common and closely monitored by investors. Sales can sometimes be interpreted negatively if they suggest a lack of confidence in the company's future, while option exercises are generally seen as a positive sign.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are a standard practice for executives to avoid accusations of insider trading when selling company stock.
- Comparing Deitrich's transactions to those of executives at similar companies (e.g., Badger Meter, Landis+Gyr) would provide a better understanding of whether these transactions are typical.
Stakeholder Impact
- Shareholders may react to the news of the CEO's stock sales, although the pre-planned nature of the transactions under Rule 10b5-1 should mitigate any negative impact.
- The transactions have no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of stock option exercise and share sales |
| 12/10/2025 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.